Increased deep processing capabilities in my country's raw materials and drug industry competition
Release time: 2011-06-09 & nbsp & nbsp & nbsp Source:
Business Club, June 7. More than 7,100 pharmaceutical manufacturers currently registered in my country，More than 4,000 have passed GMP certification，More than 1,600 raw and drug manufacturers registered by the State Food and Drug Administration，There are more than 3700 raw materials obtained by GMP certification。
In recent years，The rapid development of the pharmaceutical industry in my country，As the largest supplier in the world as the raw medicine and medicine intermediate，China has established its firm international status。
In 2010, the total output value of my country's pharmaceutical industry will reach 1256 billion yuan，increased by more than 33%year -on -year。From the perspective of production，my country can produce more than 1,500 chemical raw materials，Production capacity of more than 2 million tons，About 1/5 of the global output。In recent years，The raw and drug industry has maintained a steady growth rate，The average annual growth rate of output is more than 10%，It has become the pillar of my country's pharmaceutical industry。From the perspective of exports，More than 60%of the export of medical and health products in my country is the raw medicine。From 2002 to 2008，The average annual growth rate of the export of raw materials in my country is above 24%，Only affected by the financial crisis in 2009，The export amount has decreased，but 2010 exports reached 20.3 billion US dollars，increase to 26%，Restore high -speed growth trend。
2010，The total import and export of Chinese raw materials and drugs is 26.22 billion US dollars，increased by stake betting app25.02%year stake online sports betting-on -year，43.56%of the total import and export of my medicine。Where，The export value is 20.3 billion U.S. dollars，increased by 26.19%year -on -year; the import value was US $ 5.92 billion，year -on -year increased by 21.18%。After the short -term low in 2009，The gradual recovery of the international market and the hard demand for Chinese raw medicines，Make the import and export of Chinese raw materials restored again。
In 2010, there are 8563 companies with medical and drug export performances，increased by 8.82%year -on -year。Among them, 433 are available for more than $ 10 million an annual export value，increased by 22.32%year -on -year。Zhejiang Pharmaceutical Co., Ltd.、Zhejiang Provincial Medical and Health Products Import and Export Co., Ltd.、North China Pharmaceutical Co., Ltd.、Stone Medicine Group Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.、Zhuhai Federal Pharmaceutical Co., Ltd.、Jiangsu Lianhua Technology Co., Ltd.、Zhejiang Xinhecheng Co., Ltd.、Rizhao Jinsui Import and Export Co., Ltd.、Anhui Fengyuan Biochemical Co., Ltd.、Weifang Yingxuan Industrial Co., Ltd. ranked among the top 10 in the export of materials and drugs。A total of 21 companies have annual exports exceeding 100 million US dollars，increased by 61.5%year -on -year。Where，16 companies' exports have increased，and 9 companies have increased more than 30%，This reflects that the export operation of the leading enterprise is still good。
2010，Chinese raw materials export to 178 countries and regions，The key export market is Asia、Europe and North America，The export value of the three major export markets accounts for 87.29%of the export of all raw materials，The export increase is above 20%。The proportion and pattern of the three major markets are roughly equivalent to previous years，Where，Asian market export quantity price rises，The proportion increases by 1.06%;，But the average export price，European market slightly falls，Micro rise in North America market，less than 1%。The African market is also rising volume and price，Export value increases 25%，Latin American market exports increased by 26%，The growth rate of the raw materials and drugs of major continents exceeds 20%。
Basic stability of the export destination of Chinese raw materials。The top 10 export destination countries are India、The United States、Germany、Japan、Korea、Netherlands、My stake betting appBrazil、Italy、Spain and Belgium，stake sports betting app8 are developed countries，Only India and Brazil in developing countries，The export value of 10 countries accounted for 62.25%of the total export of the raw drug。The market growth rate of the main export destinations exceeds 20%，The largest increase in Italy，up to 36.67%，India increases with an increase of 34.72%，More countries that surpass the United States to become the largest export destination for China for China。
Rich material produced in China，The international market demand of the commodity and drug drug is strong，Large export volume，large categories of exports exceeding $ 1 billion are vitamins ($ 2.3 billion)、Central nervous system medication ($ 1.3 billion)、Anti -heat and analgesic ($ 1 billion)，Amino acid and its derivatives are also close to $ 1 billion ($ 906.3 billion)。Export volume increased by more than 40%of the large category with cardiovascular system drugs (5450%)、Linkomycin (71.64%)、Cechiac (49.19%)、During the digestive system medication (48.98%)、Drug use of respiratory system (41.86%) but tetracycline exports shrink near 30%，Anesthesia drugs and hormone exports slightly atrophied，decreased by 6.51%and 1.43%, respectively。As far as the average export price is concerned，large categories with an increase of more than 20%include tetracycline (61.5%) in large ring dectate (38.01%)、hormones (26.68%); nearly 32% of large category exports decreased，Cardiovascular system has the largest decline in medication，up to 95.92%，Vitamin category drops 16.64%，Linkicillin decreases by 13%。
China is one of the fastest growing pharmaceutical markets in the world，IMS prediction，In 2011, Chinese drug sales will increase by more than 25%，More than 50 billion U.S. dollars。will surpass France and Germany，Become the third largest pharmaceutical market in the world after the United States and Japan。2011-2015 China pharmaceutical market compound growth rate will reach 24%。
The huge population and their growth、Urbanization development、The trend of aging constitutes the cornerstone of the booming development of the Chinese pharmaceutical market。The high -speed growth of China's economy and high attention to people's livelihood issues，On the one hand, it will promote the investment in government hygiene expenses; on the other hand,，The per capita disposable income of urban residents and the rapid growth of pure income per capita Stake Sports Bettingin rural residents，It will stake sports betting appalso increase their health care expenditure，This indicates that the Chinese pharmaceutical market has huge development potential and room for development。
The rapid growth of the Chinese pharmaceutical market，It will inevitably drive the development of the import of Chinese raw materials。2010，China Western Pharmaceuticals and Pharmaceuticals reached 5.92 billion US dollars，increased by 21.18%year -on -year，Where，The number of imports increases 20.72%，The average import price rises by 0.38%。imports accounted for more than 5%of large categories include amino acids and their derivatives (8.99%)、Central nervous system medication (8.51%)、Other anti -infective medicines (7.19%)、Anti -heat and analgesic drug (5.6%)，The largest proportion is other western medicine raw materials，accounted for 57.81%，This indicates that among 19 major categories of raw materials，China needs very few varieties that need to be imported，It is either a special raw medicine that needs to be imported，Either the basic pharmaceutical raw material。The main import source country is Japan、The United States、Belgium、Germany and India，47.57%of the proportion of imported from my raw and medicine。
In the first quarter of 2011，China's raw and medicine import and export continues to maintain high -speed development，Total import and export value 7.023 billion US dollars，increased by 29.65%year -on -year。Among them, the export value is US $ 5.363 billion，increased by 31.31%year -on -year，Growth is mainly driven by quantity，Export volume increased by 39.53%，The export price fell 5.89%，Explain that the competition in the international market is still fierce，The profits of export companies are declining。Imports will rise in volume and price，The import value reaches 1.66 billion US dollars，increased by 24.55%year -on -year，Price increase exceeds the number of increases，up to 12.44%，Explain that the structure of imported products is optimizing。
In recent years，With the intensification of competition in the ray and drug industry，Chinese raw materials and pharmaceutical companies have begun to transform from producing high -end low -end intermediates to fine high -end products，Continuously extend and transfer to downstream supply chain，Domestic deep processing capabilities are gradually strengthening。At the same time，Domestic enterprises have also stake sports betting appbegun to actively obtain international certification，The quality Stake Sports Bettingof the raw and medicine has also been greatly improved。As of July 3, 2010，The number of COS certificates certified by European EDQM certification in China is 278，and as of December 31, 2010，The number of DMF files registered in the US FDA in the United States has also reached 740。
Although the advantages of Chinese raw materials in the international market are more obvious，But from the operation of 2010，There are still many obstacles and deficiencies in the development of my country's raw materials。If the overcapacity of the community has overcapacity and causes low -priced competition、Cost increase is difficult to pass on the foreign party、Export tax refund prospects are worrying、RMB appreciation pressure is greater、Insufficient industrial chain extension, etc.。But because the international pharmaceutical market is still growing，China's raw materials have obvious advantages in many varieties，Unable to replace it in the short term，The quality level of Chinese raw and drug companies is also constantly improving，We believe that the export of Chinese raw materials to maintain stable and high -speed development is expected，It is estimated that the export of Chinese raw materials in 2011 is expected to maintain a growth rate of about 20%。
The development of Chinese raw materials is always full of hope，Medical Insurance Chamber of Commerce will continue to strengthen coordination and service，To promote the sustainable and healthy development of the production and trade of China's raw materials。
In recent years，The rapid development of the pharmaceutical industry in my country，As the largest supplier in the world as the raw medicine and medicine intermediate，China has established its firm international status。
In 2010, the total output value of my country's pharmaceutical industry will reach 1256 billion yuan，increased by more than 33%year -on -year。From the perspective of production，my country can produce more than 1,500 chemical raw materials，Production capacity of more than 2 million tons，About 1/5 of the global output。In recent years，The raw and drug industry has maintained a steady growth rate，The average annual growth rate of output is more than 10%，It has become the pillar of my country's pharmaceutical industry。From the perspective of exports，More than 60%of the export of medical and health products in my country is the raw medicine。From 2002 to 2008，The average annual growth rate of the export of raw materials in my country is above 24%，Only affected by the financial crisis in 2009，The export amount has decreased，but 2010 exports reached 20.3 billion US dollars，increase to 26%，Restore high -speed growth trend。
2010，The total import and export of Chinese raw materials and drugs is 26.22 billion US dollars，increased by stake betting app25.02%year stake online sports betting-on -year，43.56%of the total import and export of my medicine。Where，The export value is 20.3 billion U.S. dollars，increased by 26.19%year -on -year; the import value was US $ 5.92 billion，year -on -year increased by 21.18%。After the short -term low in 2009，The gradual recovery of the international market and the hard demand for Chinese raw medicines，Make the import and export of Chinese raw materials restored again。
In 2010, there are 8563 companies with medical and drug export performances，increased by 8.82%year -on -year。Among them, 433 are available for more than $ 10 million an annual export value，increased by 22.32%year -on -year。Zhejiang Pharmaceutical Co., Ltd.、Zhejiang Provincial Medical and Health Products Import and Export Co., Ltd.、North China Pharmaceutical Co., Ltd.、Stone Medicine Group Weisheng Pharmaceutical (Shijiazhuang) Co., Ltd.、Zhuhai Federal Pharmaceutical Co., Ltd.、Jiangsu Lianhua Technology Co., Ltd.、Zhejiang Xinhecheng Co., Ltd.、Rizhao Jinsui Import and Export Co., Ltd.、Anhui Fengyuan Biochemical Co., Ltd.、Weifang Yingxuan Industrial Co., Ltd. ranked among the top 10 in the export of materials and drugs。A total of 21 companies have annual exports exceeding 100 million US dollars，increased by 61.5%year -on -year。Where，16 companies' exports have increased，and 9 companies have increased more than 30%，This reflects that the export operation of the leading enterprise is still good。
2010，Chinese raw materials export to 178 countries and regions，The key export market is Asia、Europe and North America，The export value of the three major export markets accounts for 87.29%of the export of all raw materials，The export increase is above 20%。The proportion and pattern of the three major markets are roughly equivalent to previous years，Where，Asian market export quantity price rises，The proportion increases by 1.06%;，But the average export price，European market slightly falls，Micro rise in North America market，less than 1%。The African market is also rising volume and price，Export value increases 25%，Latin American market exports increased by 26%，The growth rate of the raw materials and drugs of major continents exceeds 20%。
Basic stability of the export destination of Chinese raw materials。The top 10 export destination countries are India、The United States、Germany、Japan、Korea、Netherlands、My stake betting appBrazil、Italy、Spain and Belgium，stake sports betting app8 are developed countries，Only India and Brazil in developing countries，The export value of 10 countries accounted for 62.25%of the total export of the raw drug。The market growth rate of the main export destinations exceeds 20%，The largest increase in Italy，up to 36.67%，India increases with an increase of 34.72%，More countries that surpass the United States to become the largest export destination for China for China。
Rich material produced in China，The international market demand of the commodity and drug drug is strong，Large export volume，large categories of exports exceeding $ 1 billion are vitamins ($ 2.3 billion)、Central nervous system medication ($ 1.3 billion)、Anti -heat and analgesic ($ 1 billion)，Amino acid and its derivatives are also close to $ 1 billion ($ 906.3 billion)。Export volume increased by more than 40%of the large category with cardiovascular system drugs (5450%)、Linkomycin (71.64%)、Cechiac (49.19%)、During the digestive system medication (48.98%)、Drug use of respiratory system (41.86%) but tetracycline exports shrink near 30%，Anesthesia drugs and hormone exports slightly atrophied，decreased by 6.51%and 1.43%, respectively。As far as the average export price is concerned，large categories with an increase of more than 20%include tetracycline (61.5%) in large ring dectate (38.01%)、hormones (26.68%); nearly 32% of large category exports decreased，Cardiovascular system has the largest decline in medication，up to 95.92%，Vitamin category drops 16.64%，Linkicillin decreases by 13%。
China is one of the fastest growing pharmaceutical markets in the world，IMS prediction，In 2011, Chinese drug sales will increase by more than 25%，More than 50 billion U.S. dollars。will surpass France and Germany，Become the third largest pharmaceutical market in the world after the United States and Japan。2011-2015 China pharmaceutical market compound growth rate will reach 24%。
The huge population and their growth、Urbanization development、The trend of aging constitutes the cornerstone of the booming development of the Chinese pharmaceutical market。The high -speed growth of China's economy and high attention to people's livelihood issues，On the one hand, it will promote the investment in government hygiene expenses; on the other hand,，The per capita disposable income of urban residents and the rapid growth of pure income per capita Stake Sports Bettingin rural residents，It will stake sports betting appalso increase their health care expenditure，This indicates that the Chinese pharmaceutical market has huge development potential and room for development。
The rapid growth of the Chinese pharmaceutical market，It will inevitably drive the development of the import of Chinese raw materials。2010，China Western Pharmaceuticals and Pharmaceuticals reached 5.92 billion US dollars，increased by 21.18%year -on -year，Where，The number of imports increases 20.72%，The average import price rises by 0.38%。imports accounted for more than 5%of large categories include amino acids and their derivatives (8.99%)、Central nervous system medication (8.51%)、Other anti -infective medicines (7.19%)、Anti -heat and analgesic drug (5.6%)，The largest proportion is other western medicine raw materials，accounted for 57.81%，This indicates that among 19 major categories of raw materials，China needs very few varieties that need to be imported，It is either a special raw medicine that needs to be imported，Either the basic pharmaceutical raw material。The main import source country is Japan、The United States、Belgium、Germany and India，47.57%of the proportion of imported from my raw and medicine。
In the first quarter of 2011，China's raw and medicine import and export continues to maintain high -speed development，Total import and export value 7.023 billion US dollars，increased by 29.65%year -on -year。Among them, the export value is US $ 5.363 billion，increased by 31.31%year -on -year，Growth is mainly driven by quantity，Export volume increased by 39.53%，The export price fell 5.89%，Explain that the competition in the international market is still fierce，The profits of export companies are declining。Imports will rise in volume and price，The import value reaches 1.66 billion US dollars，increased by 24.55%year -on -year，Price increase exceeds the number of increases，up to 12.44%，Explain that the structure of imported products is optimizing。
In recent years，With the intensification of competition in the ray and drug industry，Chinese raw materials and pharmaceutical companies have begun to transform from producing high -end low -end intermediates to fine high -end products，Continuously extend and transfer to downstream supply chain，Domestic deep processing capabilities are gradually strengthening。At the same time，Domestic enterprises have also stake sports betting appbegun to actively obtain international certification，The quality Stake Sports Bettingof the raw and medicine has also been greatly improved。As of July 3, 2010，The number of COS certificates certified by European EDQM certification in China is 278，and as of December 31, 2010，The number of DMF files registered in the US FDA in the United States has also reached 740。
Although the advantages of Chinese raw materials in the international market are more obvious，But from the operation of 2010，There are still many obstacles and deficiencies in the development of my country's raw materials。If the overcapacity of the community has overcapacity and causes low -priced competition、Cost increase is difficult to pass on the foreign party、Export tax refund prospects are worrying、RMB appreciation pressure is greater、Insufficient industrial chain extension, etc.。But because the international pharmaceutical market is still growing，China's raw materials have obvious advantages in many varieties，Unable to replace it in the short term，The quality level of Chinese raw and drug companies is also constantly improving，We believe that the export of Chinese raw materials to maintain stable and high -speed development is expected，It is estimated that the export of Chinese raw materials in 2011 is expected to maintain a growth rate of about 20%。
The development of Chinese raw materials is always full of hope，Medical Insurance Chamber of Commerce will continue to strengthen coordination and service，To promote the sustainable and healthy development of the production and trade of China's raw materials。
